Melphalan Hydrochloride Injection shortage
Not a nationwide shortage — Fresenius Kabi has told the FDA it is discontinuing its melphalan hydrochloride injections.
- The FDA lists this under “To be discontinued” as of Nov 21, 2026: a company stopping its own product.
- 9 other companies sell the same medicine and have not reported a problem, so your pharmacy may be able to order another company’s version.
- Status
- FDA term: “To Be Discontinued”
- Products on the record
- 1
- Category
- First posted
- Sep 16, 2026
- Last updated
- Sep 16, 2026
This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD Compiled from public FDA (openFDA) and CMS (Medicaid) data sources. Editorial policy
The Bottom Line
Fresenius Kabi is stopping melphalan hydrochloride injection, and the change may be permanent. The same medicine is still listed by other makers that have not reported a shortage, though no replacement product is named in the notes.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Is Melphalan Hydrochloride Being Discontinued? Status as of Nov 21, 2026
Not as a whole, as of Nov 21, 2026. Fresenius Kabi is stopping its own version only; 9 other companies still sell the same medicine and have not reported a problem. Your pharmacy may need to order another company’s version.
The charts count only the companies that reported this shortage to the FDA; companies that haven’t reported a problem are listed after them, and the Supply-Risk rating counts them too.
Availability of the Affected Products
From the FDA shortage report: 1 product
Other Companies Listing the Same Medicine, Not Reporting a Shortage
Companies that list Melphalan Hydrochloride Injection with the FDA and have not reported a shortage (not counted in the charts above).
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Sagent Pharmaceuticals
- Dr.Reddy's Laboratories Inc
- BPI Labs LLC
- Mylan Institutional LLC
- Meitheal Pharmaceuticals Inc.
- Fosun Pharma USA Inc
- Delcath Systems, Inc.
- Avenacy Inc.
Plus 1 other dosage form of melphalan hydrochloride.
Shortage Timeline
- Sep 16, 2026 Discontinuation notice on file 1 of 1 product affected.
- Sep 16, 2026 First reported to the FDA 1 product first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
Which Melphalan Hydrochloride Products Are Affected, by Company
Only the companies that told the FDA about a supply problem are listed here, so other companies may still have stock (see Where else can I get melphalan hydrochloride?).
Company: Fresenius Kabi USA, LLC
-
Melphalan Hydrochloride Injection
- Strength / size
- Kit
- Availability
- Not stated
Notes: Discontinuation of the manufacture of the drug
Why Is Fresenius Kabi Discontinuing Melphalan Hydrochloride?
A note from Dr. Brian Staiger, PharmD · Written Oct 9, 2026
I want to explain what the FDA report says about melphalan hydrochloride injection, and it's pretty short. The FDA lists this medicine as "To Be Discontinued," but it did not give a specific reason code for why.
The report comes from Fresenius Kabi USA, LLC. Their note says they are discontinuing the manufacture of the drug, which means they are stopping production of this product. The product named in the report is the melphalan hydrochloride injection kit (NDC 63323-760-20). The report doesn't include any dates for when supply might run out, and it doesn't explain what led to the decision.
This report only reflects Fresenius Kabi's product. It doesn't tell us about any other companies that may make melphalan injection, and those are listed elsewhere on the page.
What Should I Do If I Take Melphalan Hydrochloride?
A note from Dr. Brian Staiger, PharmD · Written Oct 9, 2026
Melphalan Hydrochloride Injection is currently on the FDA drug-shortage list, and the overall supply risk is rated low (1 of 5). The report comes from one company, Fresenius Kabi USA, LLC, and covers its melphalan hydrochloride injection kit. No specific strengths are listed as affected or as still available in this record.
The reason given is that Fresenius Kabi is discontinuing manufacture of this product. That means this maker's supply problem is likely permanent. It does not mean melphalan is gone. Several other companies still have the same medicine on the market as a kit, including Sagent Pharmaceuticals, Dr. Reddy's Laboratories, Mylan Institutional, Meitheal Pharmaceuticals, Fosun Pharma USA, and others.
- Do not skip, delay, or change any treatment on your own.
- Ask your care team or pharmacy whether your treatment uses the Fresenius Kabi product. If it does, they may be able to get the same medicine from another maker, though it may not be in local stock right away.
- If they cannot find a source, ask your prescriber about options. Any change should be chosen by your clinician.
- Manufacturer contact numbers are listed on this page for reference. Pharmacies and clinics usually handle these calls.
This information comes from national, manufacturer-reported FDA data and may not match your local pharmacy's or clinic's stock. It is general information, not personal medical advice.
Quick checklist for the pharmacy counter
- Ask your pharmacy to check other companies’ versions, other strengths / sizes, package sizes, and nearby stores — the options below are a starting point.
- If this is part of an ongoing or essential regimen (for example HIV, seizure, heart, transplant, diabetes or mental-health medicines), arrange continued supply before you run out rather than rationing doses.
Where Else Can I Get Melphalan Hydrochloride?
From the current FDA NDC Directory: the same medicine from companies that have not reported a shortage and other dosage forms.
- Some listings are repackagers, which relabel another company’s product.
- A listing is not stock: these may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same Medicine From Other Companies (Not Reporting a Shortage)
The same active ingredient, dosage form and route, from companies that have not reported a shortage to the FDA.
| Product | Strength | Form / route | Company | NDC |
|---|---|---|---|---|
| Melphalan Hydrochloride | — | Kit | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-0355-41 |
| Melphalan Hydrochloride | — | Kit · Intravenous | Sagent Pharmaceuticals | 25021-0258-61 |
| Melphalan Hydrochloride | — | Kit · Intravenous | Dr.Reddy's Laboratories Inc | 43598-0392-48 |
| Melphalan Hydrochloride | — | Kit | BPI Labs LLC | 54288-0109-02 |
| Melphalan Hydrochloride | — | Kit | Mylan Institutional LLC | 67457-0195-01 |
| Melphalan Hydrochloride | — | Kit · Intravenous | Meitheal Pharmaceuticals Inc. | 71288-0132-90 |
| Melphalan Hydrochloride | — | Kit | Fosun Pharma USA Inc | 72266-0128-01 |
| Hepzato Kit | — | Kit · Intra-Arterial | Delcath Systems, Inc. | 75833-0601-01 |
| Melphalan Hydrochloride | — | Kit · Intravenous | Avenacy Inc. | 83634-0202-61 |
Other Dosage Forms of Melphalan Hydrochloride
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Injection, Solution
Therapeutic Equivalents and Pricing 16 products
Other products the FDA rates as interchangeable with the affected strengths / sizes, with what pharmacies pay for each and whether pharmacies are still buying it. Cheapest first.
| Product | Manufacturer | Package | Pharmacy cost per unit (NADAC) | FDA rated equivalent | Availability |
|---|---|---|---|---|---|
| Melphalan hydrochlorideNDC 23155-0355-41 | Heritage | 1 kit | — | AP | FDA listed |
| Melphalan HydrochlorideNDC 25021-0258-61 | Sagent | 1 kit | — | AP | FDA listed |
| Melphalan HydrochlorideNDC 31722-0362-31 | Camber | 1 kit | — | AP | FDA listed |
| Melphalan HydrochlorideNDC 43598-0392-48 | Dr.Reddy's | 1 kit | — | AP | FDA listed |
| Melphalan hydrochlorideNDC 54288-0109-02 | BPI | 1 kit | — | AP | FDA listed |
| MelphalanNDC 63323-0760-20 | Fresenius | 1 kit | — | AP | FDA listed |
| Melphalan HydrochlorideNDC 67184-0618-02 | Qilu | 1 kit | — | AP | FDA listed |
| Melphalan HydrochlorideNDC 67457-0195-01 | Mylan | 1 kit | — | AP | FDA listed |
| Melphalan hydrochlorideNDC 68083-0259-01 | Gland | 1 kit | — | AP | FDA listed |
| Melphalan hydrochlorideNDC 71288-0132-90 | Meitheal | 1 kit | — | AP | FDA listed |
| Melphalan hydrochlorideNDC 72266-0128-01 | Fosun | 1 kit | — | AP | FDA listed |
| Evomela 50 mg/10mLNDC 72893-0001-01 | Acrotech | 1 vial | — | — | FDA listed |
| Hepzato KitNDC 75833-0601-01 | Delcath | 1 kit | — | — | FDA listed |
| Melphalan HydrochlorideNDC 75907-0112-11 | Dr.Reddy's | 1 kit | — | AP | FDA listed |
| Melphalan HydrochlorideNDC 83634-0202-61 | Avenacy | 1 kit | — | AP | FDA listed |
| Melphalan HydrochlorideNDC 84679-0001-01 | Arthur | 1 kit | — | AP | FDA listed |
These have the same ingredient, strength, form and route, and the FDA rates them as substitutes (an “AB” rating in its Orange Book). The price is what pharmacies pay on average (CMS’s NADAC survey), not what you pay. Availability comes from recent pharmacy prices, not a stock check.
Other Drugs in the Same Treatment Class
These are different medicines — not other versions of melphalan hydrochloride — that fall in the same broad treatment class (antineoplastic - alkylating agents). They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Codes & Classification for pharmacists and billers
- GCN Seq No
- 019196
- GCN
- 38232
- HICL code
- 003895
- Ingredient (HICL)
- Melphalan Hcl
- HIC1 code
- V
- Therapeutic class — broad (HIC1)
- Neoplasms
- HIC2 code
- V1
- Therapeutic class — intermediate (HIC2)
- Antineoplastic Drugs
- HIC3 code
- V1A
- Therapeutic class — specific (HIC3)
- Antineoplastic - Alkylating Agents
- AHFS code
- 10:00.00.00
- AHFS class
- Antineoplastic Agents
- FDB label name
- MELPHALAN 50 MG VIAL W-DILUENT
- FDB brand name
- Melphalan Hcl
- Legend status
- F — Federal legend — prescription drug or device
- GPI-14
- 21101040102110
- GPI class
- Melphalan HCl
Where does this data come from? Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.
Other Oncology Shortages
- Valstar Preservative Free (Valrubicin) SolutionA company is discontinuing its version · 1 product
- Leuprolide Acetate InjectionA company is discontinuing its version · 1 product
- Nipent (Pentostatin) InjectionIn shortage · 1 product
- Fulvestrant InjectionA company is discontinuing its version · 1 product
- Treanda (Bendamustine Hydrochloride) InjectionA company is discontinuing its version · 1 product
- Lorbrena (Lorlatinib) TabletA company is discontinuing its version · 1 product
- Vizimpro (Dacomitinib) TabletA company is discontinuing its version · 3 products
- Ibrance (Palbociclib) CapsuleA company is discontinuing its version · 2 products
Melphalan hydrochloride Shortage FAQs
Is melphalan hydrochloride discontinued?
Only Fresenius Kabi’s version. Fresenius Kabi has told the FDA it is stopping its own product (listed under “To be discontinued” as of Nov 21, 2026), while 9 other companies still sell the same medicine and have not reported a problem (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals, Sagent Pharmaceuticals, Dr.Reddy's Laboratories and 6 more). It is not a nationwide shortage.
Which melphalan hydrochloride products are affected?
Melphalan Hydrochloride Injection (NDC 63323-0760-20). The full per-NDC list (availability, company and status) is in the table above — each NDC links to its own page.
When will melphalan hydrochloride be available again?
A discontinuation is usually permanent for that company’s product. The same medicine is still sold by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals, Sagent Pharmaceuticals, Dr.Reddy's Laboratories and 6 more, so ask your pharmacy to order another company’s version.
Can I still get melphalan hydrochloride somewhere?
Other companies (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals, Sagent Pharmaceuticals, Dr.Reddy's Laboratories and 6 more) sell the same medicine and have not reported a problem. 1 other dosage form of melphalan hydrochloride is also listed. See “Where else can I get melphalan hydrochloride?” above — stock still varies by pharmacy.
What should I do if I take melphalan hydrochloride?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another company or a different strength / size or package size, and ask your prescriber about a long-term plan before your supply runs out.
How to Read the Supply-Risk Rating
Each drug in shortage gets one point for each of five risk factors that apply to it (listed with its rating). It is our estimate across the country, not a check of your pharmacy’s shelves.
- Low0 to 2 risk factors Your pharmacy can often still get it, though it may need to be ordered.Melphalan hydrochloride is rated Low: 0 of 5 risk factors.
- Medium3 risk factors Supply is tight in several ways. Finding it may take some calling around.
- High4 or 5 risk factors, or no company found making it Few companies are left making it, or some strengths have no maker at all. It may be hard to find for a while.
Back to this drug’s rating ↑ · How we rate supply risk, in full
Where This Data Comes From
- The FDA’s drug shortage database, checked every day: the companies, their products and the codes on their boxes (NDCs), the status, the reason and the dates. See the FDA’s record for this shortage ↗
- The FDA’s NDC Directory: the other companies that make the same medicine, which the supply-risk rating counts.
- First Databank and CMS NADAC: matching the same medicine across companies, and what pharmacies pay for the equivalents.
For reference only. Check with your pharmacist, the drug’s maker or the FDA before acting on it.